Age-standardized DALYs (per 100,000)Distribution of years of life lost by major cause groupAdult mortality rate (probability of dying between 15 and 60 years per 1000 population)Distribution of causes of death among children aged < 5 years (%)Number of maternal deathsMaternal mortality ratio (per 100 000 live births)Stillbirth rate (per 1000 total births)Life expectancy at age 60 (years)nMx - age-specific death rate between ages x and x+nndx - number of people dying between ages x and x+nnqx - probability of dying between ages x and x+nlx - number of people left alive at age xnLx - person-years lived between ages x and x+nTx - person-years lived above age xex - expectation of life at age xAge-standardized NCD mortality rate  (per 100 000 population)Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years)Number of deaths among children ages 5 to 9 yearsNumber of infant deaths (between birth and 11 months)Infant mortality rate (between birth and 11 months per 1000 live births)Mortality rate among children ages 5 to 9 years (per 1000 children aged 5)Number of neonatal deaths (0 to 27 days)Neonatal mortality rate (0 to 27 days) per 1000 live births) (SDG 3.2.2)Number of deaths among children under-fiveUnder-five mortality rate (per 1000 live births) (SDG 3.2.1)Number of deaths among children ages 10 to 14 yearsMortality rate among children ages 10 to 14 years (per 1000 children aged 10)Skilled health professionals density (per 10 000 population)Estimated direct deaths from major conflicts (per 100 000 population)Average of 13 International Health Regulations core capacity scores, 1st version of the questionnaireAverage death rate due to natural disasters (per 100 000 population)Life expectancy at birth (years)Healthy life expectancy (HALE) at birth (years)Healthy life expectancy (HALE) at age 60 (years)Mortality rate attributed to unintentional poisoning (per 100 000 population)Average of 13 International Health Regulations core capacity scores, SPAR version, 1st editionCrude suicide rates (per 100 000 population)Girls aged 15 years old that received the recommended doses of HPV vaccine (%)Women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (%)Adolescent birth rate (per 1000 women)Reported number of people requiring interventions against NTDsBirths attended by skilled health personnel (%)Concentrations of fine particulate matter (PM2.5)Ambient and household air pollution attributable death rate (per 100 000 population)Ambient and household air pollution attributable death rate (per 100 000 population, age-standardized)New HIV infections (per 1000 uninfected population)Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2)Maternal mortality ratio (per 100 000 live births) - Country reported estimatesDonor disbursements (Million, constant 2009 US$)Antenatal care coverage - at least four visits (%)Radiotherapy units (per 1 000 000 population)Donor commitments (Million, constant 2009 US$)Number of licensed qualified surgeons actively workingNumber of licensed qualified anaesthesiologists actively workingNumber of licensed qualified obstetricians actively workingBiomedical engineers density (per 10 000 population)Number of biomedical engineersBiomedical technicians density (per 10 000 population)Number of biomedical techniciansStatus of indigenous malaria casesEstimated number of malaria casesEstimated malaria incidence (per 1000 population at risk)Number of indigenous malaria casesEstimated number of malaria deathsEstimated malaria mortality rate (per 100 000 population)Smear-positive tuberculosis case-detection rate (%)Tuberculosis - new and relapse cases (TB_c_newinc)Minimum legal drinking ageNew cases: pulmonary smear-negativeNew cases: pulmonary smear unknown/not doneNew cases: otherRetreatment cases: treatment after failure (pulmonary smear and/or culture positive)Retreatment cases: treatment after default (pulmonary smear and/or culture positive)Retreatment cases: otherSmear-positive tuberculosis treatment-success rate (%)Treatment success rate for new pulmonary smear-negative and extrapulmonary tuberculosis casesConfirmed cases of MDR-TBConfirmed cases of MDR-TB started treatment for MDR-TB (%)Estimated MDR-TB cases among notified pulmonary TB casesNumber of prevalent tuberculosis casesSecond-line drug susceptibility testing (DST) availableLaboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population)Laboratories providing tuberculosis diagnostic services using culture (per 5 million population)Laboratories providing drug susceptibility testing (DST) (per 5 million population)Total number of notified TB casesTuberculosis effective treatment coverage (%)Treatment success rate: new TB casesTreatment success rate: previously treated TB casesTreatment success rate: HIV-positive TB casesTreatment success rate for patients treated for MDR-TB (%)Treatment success rate: XDR-TB casesConfirmed cases of RR-/MDR-TBCases started on MDR-TB treatmentPreviously treated cases tested for RR-/MDR-TB (%)New cases tested for RR-/MDR-TB (%)TB patients with known HIV status (%)Tested TB patients HIV-positive (%)Estimated number of MDR/RR-TB incident casesNumber of deaths due to tuberculosis, excluding HIVDeaths due to tuberculosis among HIV-negative people (per 100 000 population)Number of incident tuberculosis casesIncidence of tuberculosis (per 100 000 population per year)Incidence of tuberculosis (per 100 000 population) (HIV-positive cases)Number of incident tuberculosis cases,  (HIV-positive cases)Tuberculosis treatment coverageNumber of incident tuberculosis cases in children aged 0 - 14Tuberculosis - new and relapse casesNew or unknown treatment history cases: Pulmonary, bacteriologically confirmedNew cases: Pulmonary, smear-positiveNew or unknown treatment history cases: Pulmonary, clinically diagnosedNew cases: extrapulmonaryRelapse cases: Pulmonary, bacteriologically confirmedRelapse cases: Pulmonary, clinically diagnosedRelapse cases: extrapulmonaryRelapse cases (pre-2013 definition)Previously treated  cases, excluding relapseTreatment history unknownNew cases: Pulmonary, smear-negative/unknown/not done and other new casesChildren aged <5 years wasted for age (%)Low birth weight, prevalence (%)Low birth weight (in thousands)Infants exclusively breastfed for the first six months of life (%)Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)Pneumococcal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%)Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%)Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)Hib (Hib3) immunization coverage among 1-year-olds (%)Polio (Pol3) immunization coverage among 1-year-olds (%)Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)Number of reported deaths from choleraNumber of reported cases of choleraCholera case fatality ratePoliomyelitis - number of reported casesDiphtheria - number of reported casesPertussis - number of reported casesTotal tetanus - number of reported casesYellow fever - number of reported casesMumps - number of reported casesCongenital Rubella Syndrome - number of reported casesNeonatal tetanus - number of reported casesTotal rubella - number of reported casesMeasles - number of reported casesNumber of new leprosy casesNumber of leprosy cases registered for treatment (prevalence)Number of new leprosy cases with G2DNumber of new leprosy cases among children (less than 15 years of age)Number of new leprosy cases with G2D among children (less than 15 years of age)Number of new leprosy cases among femalesNumber of pigs in the countryPresence of roaming backyard pigsNew leprosy cases with G2D rate per 1 000 000 populationNew leprosy case detection rate per 1 000 000 populationLeprosy registered prevalence rate per 1 000 000 populationNew leprosy child case detection rate (less than 15 years of age) per 1 000 000 child populationStatus of endemicity of Taenia soliumDistribution of years of life lost by broader causes (%) - InjuriesPreterm birth rate (per 100 live births)Deaths due to HIV/AIDS (per 100 000 population)Births by caesarean section (%)Completeness of cause-of-death data (%)Hospital beds (per 10 000 population)Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%)Age-standardized death rates, colon and rectum cancers, per 100,000Age-standardized death rates, oesophagus cancer, per 100,000Age-standardized death rates, alcohol use disorders, per 100,000Age-standardized death rates, mouth and oropharynx cancer, per 100,000Age-standardized death rates, falls, per 100,000Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000Age-standardized death rates (15+ years), poisoning, per 100,000Age-standardized death rates, fires, per 100,000Age-standardized death rates (15+ years), violence, per 100,000Age-standardized death rates, drownings, per 100,000Age-standardized death rates, violence, per 100,000Age-standardized death rates, self-inflicted injury, per 100,000Age-standardized death rates, road traffic accidents, per 100,000Age-standardized death rates, liver cirrhosis, per 100,000Age-standardized death rates, breast cancer, per 100,000Age-standardized death rates, liver cancer, per 100,000Age-standardized death rates, poisoning, per 100,000National drinking guidelines, 2010MonitoringTreatment, servicesProduction in 1000s hectolitresImports in 1000s hectolitresSales of beer in 1000s hectolitresSales of wine in 1000s hectolitresExports of wine (grape) in 1000s hectolitresExports of spirits in 1000s hectolitresExports of beer (barley) in 1000s hectolitresSales of spirits in 1000s hectolitresPerceived trend in productionPerceived trend in importsPerceived trend in salesPerceived trend in exportsPoint prevalence (%), drug use disorders, 15+ yearsPoint prevalence (%), alcohol use disorders, 15+ yearsAge-standardized death rates, cerebrovascular disease, per 100,000Age-standardized death rates, diabetes mellitus, per 100,000Age-standardized death rates, ischaemic heart disease, per 100,000Age-standardized death rates, other unintentional injuries, per 100,000Age-standardized death rates, prematurity and low birth rate, per 100,000Age-standardized DALYs, alcohol use disorders, per 100,000Age-standardized DALYs, breast cancer, per 100,000Age-standardized DALYs, cerebrovascular disease, per 100,000Age-standardized DALYs, colon and rectum cancers, per 100,000Age-standardized DALYs, diabetes mellitus, per 100,000Age-standardized DALYs, drownings, per 100,000Age-standardized DALYs, falls, per 100,000Age-standardized DALYs, fires, per 100,000Age-standardized DALYs, ischaemic heart disease, per 100,000Age-standardized DALYs, liver cancer, per 100,000Age-standardized DALYs, liver cirrhosis, per 100,000Age-standardized DALYs, mouth and oropharynx cancer, per 100,000Age-standardized DALYs, oesophagus cancer, per 100,000Age-standardized DALYs, other unintentional injuries, per 100,000Age-standardized DALYs, poisoning, per 100,000Age-standardized DALYs, road traffic accidents, per 100,000Age-standardized DALYs, self-inflicted injury, per 100,000Age-standardized DALYs, violence, per 100,000Age-standardized DALYs, prematurity and low birth rate, per 100,000Social costs of alcohol use in millions US$Age-standardized death rates, alcohol and drug use disorders, per 100 000Age-standardized DALYs, alcohol and drug use disorders, per 100 000Hospital discharges, alcoholic liver disease, per 100,000Alcoholic psychosis, incidence, per 100,000Alcohol-related disease mortality, per 100,000 (15+ years)Alcohol-related injury mortality, per 1,000Excise tax as a per cent of the total retail price for 1 litre of pure alcoholPrices for alcoholic beverages (average, US$)Excise tax as a per cent of the retail price of alcoholic beveragesAlcohol, patterns of drinking scoreAlcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year averageAlcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)Alcohol, tourist consumption (in litres of pure alcohol)Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)Alcohol, drinkers only per capita (15+)consumption in litres of pure alcoholAlcohol, abstainers lifetime (%)Alcohol, former drinkers (%)Alcohol, consumers past 12 months (%)Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CIAlcohol-related road traffic crashes, per 100,000 populationAlcohol-related road traffic crashes (% of all traffic crashes)Cautions and arrests for drink-driving, per 100,000 populationAlcoholic beverage legally definedAdopted written national policy on alcoholAdvertising restrictions on cable televisionStandard drink measures, in grams per unitAdvertising restrictions on national televisionAdvertising restrictions on national radioAdvertising restrictions on local radioNational legislation to prevent illegal alcoholAdvertising restrictions on billboardsAdvertising restrictions on the internetAdvertising restrictions in print mediaAdvertising restrictions at cinemasAdvertising restrictions at point-of-saleRestrictions on product placement on national televisionRestrictions on product placement on cable televisionRandom breath testing (RBT) useExcise tax on alcoholic beveragesDuty paid or excise stamp on alcohol containerValue-added tax (VAT) on alcohol (%)Health warning labels on alcohol containersHealth warning labels on alcohol advertisingOff-premise sales restrictions on outlet densityOff-premise sales restrictions at petrol stationsOff-premise sales restrictions on daysOff-premise sales restrictions on hoursOff-premise sales restrictions at specific eventsOff-premise sales restrictions on placesOn-premise sales restrictions on outlet densityOn-premise sales restrictions on daysOn-premise sales restrictions on hoursOn-premise sales restrictions on placesRestrictions on sales promotion from producers (parties, events)On-premise sales restrictions to intoxicated persons (archived)Restrictions on sales promotion from owners of pubs and bars (alcohol for free)Restrictions on sponsorship of youth eventsOn-premise sales restrictions at specific eventsRestrictions on sponsorship of sporting eventsRestrictions on sales promotion from retailers (sales below cost)Government monopoly on productionGovernment monopoly on retail salesLicence required for productionLicence required for retail salesRestrictions on alcohol use in public placesAlcohol use disorders (15+), 12 month prevalence (%) with 95%Awareness activitiesRoad traffic injuries, age-standardized death rates (15+), per 100,000 populationLiver cirrhosis, age-standardized death rates (15+), per 100,000 populationAge limits on-premise serviceAlcohol, consumption of pure alcohol by type of beverage (%)Legal blood alcohol concentration (BAC) limitsAnnual revenues from alcohol excise tax in millions US$Alcohol expenditure as a per cent of total household expenditureAlcoholic excise tax revenue as a per cent of government revenueAlcohol, abstainers past 12 months (%)Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%)Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2)Training in screening and brief interventions for alcohol problemsDesignation of alcohol tax revenues to health servicesCounselling to pregnant women with alcohol problemsAlcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 202515-19 years old abstainers, lifetime (%)15-19 years old former drinkers (%)Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities)Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images (see E14b_movies_anti_tob_ads)Subnational bans on tobacco advertising, promotion and sponsorshipSponsored eventsBan on entities other than tobacco companies/tobacco industry publicizing the Corporate Social Responsibility� activities of the tobacco companiesBan on tobacco companies/tobacco industry publicizing their “Corporate Social Responsibility” activitiesYouth indicator 1 definitionAdult smokeless tobacco use indicator definitionRepresentativeness of survey of adults - smokelessRepresentativeness of survey of youth - smokelessCompliance with regulations on smoke-free environments (national legislation)Compliance with bans on promotion and sponsorshipComprehensive bans in place subnationallyAdult indicator 1 rateYouth indicator 1 rateYouth smokeless tobacco use indicator rateAlcohol, average daily intake in grams among drinkers with 95%CICautions and arrests for public drunkenness, per 100,000 populationAlcohol, harmful use (15+), 12 month prevalence (%) with 95%CIFramework of national alcohol policyCentral coordinating entity for alcohol policy implementationSectors represented in national alcohol policyAdvertising restrictions on social mediaRestrictions on product placement in films/moviesGovernment support for community actionPenalties for drink drivingLevel of taxation adjusted for inflationNumber of standard alcoholic drinks displayed on containersConsumer information about calories, additives, etc on containersAlcohol content displayed on containersPenalties for marketing infringements15-19 years old heavy episodic drinkers (population), % with 95%CIAlcohol-attributable fractions (15+), liver cirrhosis deaths (%)Alcohol-attributable Years of Life Lost (YLL) scoreAge limits off-premise salesPsychiatrists working in mental health sector (per 100 000 population)Beds in mental hospitals (per 100 000 population)Beds for mental health in general hospitals (per 100 000 population)Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CIAge-standardized suicide rates (per 100 000 population)Ban on sale of smokeless tobacco productsSystem for monitoring alcohol-related harmCounselling to children in families with alcohol problemsData collection on alcohol-related health indicatorsMental health planCigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark (see W21_emissions_quant_A)Complete ban on tobacco vending machinesBan on advertising: Point of saleAppearance of tobacco products in TV and/or filmsCompliance with bans on direct advertisingAdult survey age range - smokelessAdult indicator 1 definitionYouth smokeless tobacco use indicator definitionRepresentativeness of youth surveyName of survey of adults - smokelessName of survey of youthProcess evaluation was employed to assess implementationYouth survey age rangeAdult indicator 2 rateAdult smokeless tobacco use indicator rateAction Plan for implementation of alcohol policyAdopted written national policy on alcohol, year revisedSobriety checkpointsNational guidelines for the prevention and reduction of alcohol-related harm in schools15-19 years old heavy episodic drinkers (drinkers only), %Alcohol-attributable fractions (15+), road traffic crash deaths (%)Alcohol-attributable fractions, all-cause deaths (%)15-19 years old, current drinkers (%)Stand-alone law for mental healthMental health units in general hospitals (per 100 000 population)Mental health outpatient facilities (per 100 000 population)Community-based interventions/projects involving stakeholdersPrevention/counselling at workplaces for those with alcohol problemsInterventions/projects actively involving young people and civil societyMental health policyAlcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI, 2010 ( already in archive)Adult survey age rangeYouth survey age range - smokelessLevel of adoption of national alcohol policyAdopted written national policy on alcohol, year adoptedPrice measuresDetection of marketing infringementsServer trainingPublic-funded alcohol research/monitoring programmesPublic funds designated for alcohol research/monitoring programmes, in EurosNational treatment policy for alcohol use disordersNational surveys on drink-drivingPersons with alcohol use disorders receiving treatment (%)Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CIRepresentativeness of survey of adultsName of survey of adultsName of survey of youth - smokelessAdult indicator 2 definitionNational guidelines for alcohol problem prevention and counselling at workplacesPsychologists working in mental health sector (per 100 000 population)Nurses working in mental health sector (per 100 000 population)Social workers working in mental health sector (per 100 000 population)Mental hospitals (per 100 000 population)Regular reports from national monitoring systems15-19 years old total alcohol consumption in litres of pure alcoholMental hospital admissions (per 100 000 population)Outpatient visits (per 100 000 population)Mental health units in general hospitals admissions (per 100 000 population)Stand-alone policy or plan for mental healthSubnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in placeBan on display of tobacco products at points of saleLaw requires fines for violations of indirect advertising bans,2015Law requires fines for violations of direct advertising bans, 2015Compliance of ban on smoking in HEALTH-CARE FACILITIESCompliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIESCompliance of ban on smoking in UNIVERSITIESCompliance of ban on smoking in INDOOR OFFICESCompliance of ban on smoking in RESTAURANTSCompliance of ban on smoking in PUBS AND BARSCompliance of ban on smoking in PUBLIC TRANSPORTCompliance of ban on smoking in GOVERNMENT FACILITIESCompliance of ban on sponsored eventsCompliance of ban on appearance of tobacco products in TV and/or filmsCompliance of ban on appearance of tobacco brands in TV and/or films (product placement)Compliance of ban on brand name of non-tobacco products used for tobacco productCompliance of ban on non-tobacco goods AND services identified with tobacco brand namesCompliance of ban on promotional discountsCompliance of ban on free distribution of tobacco products in the mail or through other meansCompliance of ban on advertising at point of saleCompliance of ban on advertising on billboards and outdoor advertisingCompliance of ban on advertising on local magazines and newspapersCompliance of ban on advertising on national TV and radioLevel of enforcement of BAC limitsLegislation on alcohol testing at workplacesStandard drink definedNational systems for monitoring alcohol consumption and harmsNational surveys on adult alcohol consumptionNational surveys on youth alcohol consumptionHeavy episodic drinking (youth 15 -19 years) past 30 days (%)Cancer, age-standardized death rates (15+), per 100,000 populationAlcohol-attributable fractions (15+), cancer deathsNational legislation to prevent illegal alcohol salesHeavy episodic drinking (youth 15 -19 years), drinkers only, past 30 days (%)15-years old any alcoholic beverage consumed in past 12 months, (%)15-years old any alcoholic beverage consumed in past 30 days, (%)15-years old, any alcoholic beverage consumed at least once a week, (%)15-years old first drink at 13 years or younger, (%)Publication year of the policy or plan (latest revision)Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CIAlcohol, tourist consumption (in litres of pure alcohol) (three-year average)Existence of a formal pre-hospital care systemGross national income per capita (Atlas method)Income levelPopulationChild maltreatment: Extent of implementation of home-visiting programmesYouth violence: Extent of implementation of life-skills and social development programmesIntimate partner violence: Extent of implementation  of dating violence prevention programmesElder abuse: Extent of implementation  of caregiver-support programmesExtent of implementation of  mental health services for victims of all types of violenceExtent of implementation of child protection servicesExtent of implementation of medico-legal services for victims of sexual violenceNumber of registered vehiclesDistribution of road traffic deaths by type of road user (%)Blood Alcohol Concentration (BAC) limit for driversExistence of a national seat-belt lawApplicability of seat-belt law to all occupantsSeat-belt wearing rate (%)Existence of a national child-restraint lawExistence of national speed limitsMaximum speed limitsLaw requires helmet to be fastenedApplicability of national motorcycle helmet law to all occupantsExistence of a national drink-driving lawDefinition of drink-driving by BACAttribution of road traffic deaths to alcohol (%)Existence of a road safety lead agencyExistence of a national road safety strategyAvailability of funding for national road safety strategyExistence of a universal access telephone number for pre-hospital careVehicle standardsEstimated number of road traffic deathsEstimated road traffic death rate (per 100 000 population)Estimates of number of homicidesEstimates of rates of homicides per 100 000 populationProportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 monthsProportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in their lifetimeAntiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%)Estimated number of people eligible for antiretroviral therapy according to 2010 guidelinesEstimated number of tests performed where results were received by a person (testing volume), estimated number per 1000 populationReported number of tests performed where results were received by a person (testing volume), reporting periodReported number of tests performed where results were received by a person (testing volume)Reported number of children receiving antiretroviral therapyEstimated number of children needing antiretroviral therapy based on WHO methodsEstimated antiretroviral therapy coverage among childrenEstimated number of people (all ages) living with HIVNumber of people dying of HIV-related causesReported number of people receiving antiretroviral therapyEstimated antiretroviral therapy coverage among people living with HIV (%)Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmissionEstimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmissionEstimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmissionPrevalence of HIV among adults aged 15 to 49 (%)Number of new HIV infectionsWater, sanitation and hygiene attributable deaths ('000) in children under 5 yearsWater, sanitation and hygiene attributable deaths per 100'000 capitaWater, sanitation and hygiene  attributable deaths per 100'000 children under 5 yearsWater, sanitation and hygiene attributable DALYs ('000)Water, sanitation and hygiene attributable DALYs ('000) in children under 5 yearsWater, sanitation and hygiene attributable DALYs per 100'000 capitaWater, sanitation and hygiene  attributable DALYs per 100'000 children under 5 yearsUV radiationUV radiation attributable deathsUV radiation attributable deaths per 100'000 capitaUV radiation attributable DALYs ('000)UV radiation attributable DALYs per 100'000 capitaPopulation using solid fuels (%)Age-standardized deaths attributable to the environment (per 100 000 population)Disability-adjusted life years (DALYs) attributable to the environmentAge-standardized DALYs attributable to the environment (per 100 000 population)Deaths attributable to the environmentDisability-adjusted life years (DALYs) attributable to the environment (%)Deaths attributable to the environment (%)DALYs attributable to ambient air pollution (age-standardized)Access restrictionsRestriction and inspection of facilitiesInformation requirementsSafety requirementsTraining requirementsExistence of national regulationExistence of subnational regulationAmbient air pollution attributable DALYs (please see AIR_7)Population using at least basic drinking-water services (%)Population using safely managed drinking-water services (%)Population using at least basic sanitation services (%)Population using safely managed sanitation services (%)Population with basic handwashing facilities at home (%)Population practising open defecation (%)Ambient air pollution attributable death rate (per 100 000 population)Ambient air pollution attributable deathsAmbient air pollution attributable death rate (per 100 000 population, age-standardized)Ambient air pollution attributable DALYsAmbient air pollution attributable DALYs  in children under 5 yearsAmbient air pollution attributable DALYs  (per 100 000 population)Ambient air pollution attributable DALYs  (per 100 000 population, age-standardized)Ambient air pollution attributable YLLsAmbient air pollution attributable YLL in children under 5 yearsAmbient air pollution attributable deaths in children under 5 yearsAmbient air pollution  attributable deaths per 100'000 children under 5 yearsAmbient air pollution  attributable DALYs per 100'000 children under 5 yearsAmbient air pollution attributable DALYs in children under 15 yearsAmbient air pollution attributable deaths in children under 15 yearsAmbient air pollution attributable YLL in children under 15 yearsHousehold air pollution attributable deathsHousehold air pollution attributable death rate (per 100 000 population)Household air pollution attributable death rate (per 100 000 population, age-standardized)Household air pollution attributable DALYsHousehold air pollution attributable DALYs (per 100 000 population)Household air pollution attributable DALYs (per 100 000, age-standardized)Household air pollution attributable deaths in children under 5 yearsHousehold air pollution attributable DALYs in children under 5 yearsHousehold air pollution attributable deaths in children under 15 yearsHousehold air pollution attributable DALYs in children under 15 yearsAttributable fraction of diarrhoea to inadequate hygieneNumber of diarrhoea deaths from inadequate hygieneNumber of diarrhoea DALYs from inadequate hygieneAttributable fraction of diarrhoea to inadequate water, sanitation and hygieneNumber of diarrhoea deaths from inadequate water, sanitation and hygieneNumber of diarrhoea DALYs from inadequate water, sanitation and hygieneSDG 3.9.2 WASH deathsExclusive breastfeeding under 6 months (%)Prevalence of anaemia in children aged 6–59 months (%)Number of children aged 6–59 months with anaemia (thousands)Number of women of reproductive age (aged 15-49 years) with anaemia (thousands)Number of non-pregnant women (aged 15-49 years) with anaemia (thousands)Number of pregnant women (aged 15-49 years) with anaemia (thousands)Prevalence of anaemia in pregnant women (aged 15-49) (%)Prevalence of anaemia in non-pregnant women (aged 15-49) (%)Prevalence of anaemia in women of reproductive age (aged 15-49) (%)Deaths in children aged <5 years, by causeDeaths in children aged <5 years, by cause (per 1 000 live births)Mean BMI (kg/m&#xb2;) (crude estimate)Mean fasting blood glucose (mmol/l) (crude estimate)Mean systolic blood pressure (crude estimate)Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate)Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate)Mean systolic blood pressure (age-standardized estimate)Prevalence of obesity among adults, BMI &GreaterEqual; 30 (age-standardized estimate) (%)Prevalence of obesity among adults, BMI &GreaterEqual; 30 (crude estimate) (%)Prevalence of underweight among adults, BMI < 18.5 (age-standardized estimate) (%)Prevalence of underweight among adults, BMI < 18.5 (crude estimate) (%)Mean BMI (kg/m&#xb2;) (age-standardized estimate)Prevalence of overweight among adults, BMI &GreaterEqual; 25 (age-standardized estimate) (%)Prevalence of overweight among adults, BMI &GreaterEqual; 25 (crude estimate) (%)Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (crude estimate) (%)Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (crude estimate) (%)Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (crude estimate) (%)Raised fasting blood glucose (>= 7.0 mmol/L) (crude estimate)Raised fasting blood glucose (>=7.0 mmol/L) (age-standardized estimate)Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%)Prevalence of insufficient physical activity among school going adolescents aged 11-17 (crude estimate)Mean fasting blood glucose (mmol/l) (age-standardized estimate)Total NCD Deaths (in thousands)Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory diseasePremature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths (%)Mean total cholesterol,  crudePrevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%)Mean total cholesterol,  age-standardizedMean Non-HDL cholesterol, crudeMean Non-HDL cholesterol, age-standardizedMean HDL cholesterol, crudeMean HDL cholesterol, age-standardizedPrevalence of controlled hypertension among adults aged 30-79 years with hypertension, age-standardizedPrevalence of previous diagnosis of hypertension among adults aged 30-79 with hypertension, age-standardizedPrevalence of hypertension among adults aged 30-79 years, age-standardizedPrevalence of treatment (taking medicine) for hypertension among adults aged 30-79 with hypertension, age-standardizedPrevalence of controlled hypertension among adults aged 30-79 years with hypertension, crudePrevalence of previous diagnosis of hypertension among adults aged 30-79 with hypertension, crudePrevalence of hypertension among adults aged 30-79 years, crudePrevalence of treatment (taking medicine) for hypertension among adults aged 30-79 with hypertension, crudeGeneral availability of colon cancer screening at the primary health care levelGeneral availability of breast cancer screening (by palpation or mammogram) at the primary health care levelGeneral availability of cervical cytology at the primary health care levelGeneral availability of total cholesterol measurement at the primary health care levelGeneral availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care levelGeneral availability of urine testing for albuminGeneral availability of ACE inhibitors in the public health sectorGeneral availability of aspirin (100 mg) in the public health sectorGeneral availability of bronchodilators in the public health sectorGeneral availability of CC blockers in the public health sectorGeneral availability of insulin in the public health sectorGeneral availability of metformin in the public health sectorGeneral availability of nicotine replacement therapy in the public health sectorGeneral availability of oral morphine in the public health sectorGeneral availability of statins in the public health sectorGeneral availability of steroid inhalers in the public health sectorGeneral availability of thiazide diuretics in the public health sectorExistence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDsExistence of population-based cancer registryExistence of an NCD surveillance and monitoring system in place to enable reporting against the nine global NCD targetsExistence of operational policy/strategy/action plan for chronic respiratory diseasesExistence of operational policy/strategy/action plan for diabetesExistence of operational policy/strategy/action plan for cardiovascular diseasesExistence of operational policy/strategy/action plan for cancerExistence of operational policy/strategy/action plan to decrease tobacco useExistence of operational policy/strategy/action plan to reduce physical inactivityExistence of operational policy/strategy/action plan to reduce the harmful use of alcoholExistence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDsExistence of a national multisectoral commission, agency or mechanism for NCDsExistence of a set of national NCD indicators and has set time-bound national targets for these indicatorsExistence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factorsExistence of any policies on marketing of foods to childrenExistence of any policies to reduce population salt consumptionImplementation of diet and/or physical activity public awareness programGeneral availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care levelGeneral availability of diabetes testing (by HbA1c) at the primary health care levelExistence of a diabetes registryHas a STEPS survey or a comprehensive health examination survey every 5 yearsExistence of national screening program for breast cancerExistence of national screening program for cervical cancerMost widely used screening method in national cervical cancer screening programType of national cervical cancer screening programCoverage of national cervical cancer screening program (%)Existence of national HPV vaccination programmeGeneral availability of retinal photocoagulation in the public health systemGeneral availability of dialysis in the public health systemGeneral availability of renal replacement by transplantation in the public health systemGeneral availability of coronary bypass or stenting in the public health systemGeneral availability of thrombolytic therapy in the public health systemGeneral availability of beta blockers in the public health sectorGeneral availability of sulphonylurea(s) in the public health sectorProvision for care of acute stroke and rehabilitation in more than 50% of public sector health facilitiesGeneral availability of palliative care in community or home-based care in the public health systemGeneral availability of palliative care in primary health care in the public health systemProvision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilitiesAvailability of cardiovascular risk stratification in 50% or more primary health care facilitiesExistence of a set of time-bound national targets based on WHO guidanceExistence of operational policy/strategy/action plan for oral healthImplementation of physical activity public awareness programExistence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approachExistence of a register of patients who had rheumatic fever and rheumatic heart diseaseHas systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart diseaseExistence of tax on sugar-sweetened beveragesExistence of national policies on saturated fatty acidsExistence of national policies on trans-fatty acid eliminationGeneral availability of Angiotensin II receptor blockers (ARBs) in the public health sectorGeneral availability of bone marrow transplantation in the public health systemExistence of tax on foods high in fat, sugars or saltExistence of price subsidies for healthy foodsExistence of tax incentives to promote physical activityExistence of operational policy/strategy/action plan for eye healthExistence of operational policy/strategy/action plan for hearing healthExistence of operational policy/strategy/action plan to reduce overweight/obesityExistence of national guidelines for physical activityImplementation of a recent mass participation eventImplementation of a nutrition public awareness programExistence of a national target on NCD mortalityExistence of a national target on alcoholExistence of a national target on physical inactivityExistence of a national target on saltExistence of a national target on tobaccoExistence of a national target on blood pressure / hypertensionExistence of a national target on diabetesExistence of a national target on obesityExistence of a national target on drug therapy and counsellingExistence of a national target on essential medicines and technologiesHas conducted a recent, national adult risk factor survey covering harmful alcohol useHas conducted a recent, national adult risk factor survey covering tobacco useHas conducted a recent, national adult risk factor survey covering unhealthy dietHas conducted a recent, national adult risk factor survey covering physical inactivityHas conducted a recent, national adult risk factor survey covering raised blood glucose/diabetesHas conducted a recent, national adult risk factor survey covering raised total cholesterolHas conducted a recent, national adult risk factor survey covering raised blood pressure/hypertensionHas conducted a recent, national adult risk factor survey covering salt/sodium intakeHas conducted a recent, national adult risk factor survey covering overweight and obesityGeneral availability of dilated fundus examination at the primary health care levelGeneral availability of foot vibration perception by tuning fork at the primary health care levelGeneral availability of urine strips for glucose and ketone measurement at the primary health care levelGeneral availability of blood pressure measurement at the primary health care levelGeneral availability of peak flow measurement at the primary health care levelGeneral availability of spirometry at the primary health care levelGeneral availability of Fixed dose combination avail (lisinopril + amlodipine) in the public health sectorGeneral availability of Fixed dose combination avail (lisinopril + hydrochlorothiazide) in the public health sectorGeneral availability of Fixed dose combination avail (telmisartan + amlodipine) in the public health sectorGeneral availability of Fixed dose combination avail (telmisartan + hydrochlorothiazide) in the public health sectorGeneral availability of combination budesonide formoterol inhaler in the public health sectorGeneral availability of diabetic retinopathy screening in the public health systemGeneral availability of alteplase for acute stroke management in the public health systemExistence of evidence-based national guidelines/protocols/standards for the management of cardiovascular diseasesExistence of evidence-based national guidelines/protocols/standards for the management of diabetesExistence of evidence-based national guidelines/protocols/standards for the management of cancerExistence of evidence-based national guidelines/protocols/standards for the management of chronic respiratory diseasesExistence of evidence-based national guidelines/protocols/standards for the management of alcohol use disordersExistence of evidence-based national guidelines/protocols/standards for the management of tobacco dependenceExistence of evidence-based national guidelines/protocols/standards for the management of overweight/obesityExistence of evidence-based national guidelines/protocols/standards for the management of physical inactivityGeneral availability of cancer centres or cancer departments at tertiary level in the public sectorGeneral availability of pathology services (laboratories) in the public sectorGeneral availability of cancer surgery in the public sectorGeneral availability of chemotherapy in the public sectorGeneral availability of radiotherapy in the public sectorExistence of national guidelines for physical activity for children under 5Existence of national guidelines for physical activity for adultsExistence of national guidelines for physical activity for children and adolescents aged 5-19Existence of national guidelines for physical activity for older adultsExistence of policy promoting physical activity: walking and cyclingExistence of policy promoting physical activity: workplace initiativesExistence of policy promoting physical activity: active ageingExistence of policy promoting physical activity: community-based and sports initiativesExistence of policy promoting physical activity: public open spacesExistence of policy promoting physical activity: childcare settingsAnnual incidence of dracunculiasis casesDracunculiasis certification status of countries at the beginning of the yearStatus of elimination of trachoma as a public health problemStatus of endemicity of buruli ulcderType of nomenclature systemHealth technology (medical device) national policyUnit in the Ministry of Health responsible for the management of medical devicesProcurement of medical devices carried out at the national levelAvailability of national list of approved medical devices for procurement or reimbursementNational guidelines, policies or recommendations on the procurement of medical devicesAvailability of technical specifications of medical devices to support procurement or donationsTypes of lists recommending health technology for high burden diseasesUse of nomenclature systemTotal density per million population: Linear AcceleratorTotal density per million population: Telecobalt UnitTotal density per million population: Radiotherapy unitsHuman development index rankGender inequality index rankICT Development Index (IDI) rankICT Development Index (IDI)Percentage of individuals using the InternetMobile-cellular telephone subscriptions per 100 inhabitantsCivil registration coverage of cause-of-death (%)Ill-defined causes in cause-of-death registration (%)Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), model-based estimatesStunting prevalence among children under 5 years of age (% height-for-age <-2 SD), model-based estimatesOverweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), survey-based estimatesStunting prevalence among children under 5 years of age (% height-for-age <-2 SD), survey-based estimatesUnderweight prevalence among children under 5 years of age   (% weight-for-age <-2 SD), survey-based estimatesWasting prevalence among children under 5 years of age (% weight-for-height <-2 SD), survey-based estimatesSevere wasted prevalence among children under 5 years of age   (% weight-for-height <-3 SD), survey-based estimatesTax administration: Bans or limits on duty free imports by travellersTax administration: Tax stamps applied on tobacco productsTobacco excises increased over the survey periodAverage - taxes as a % of cigarette price - other taxesAverage - taxes as a % of cigarette price - specific exciseAverage - taxes as a % of cigarette price - total taxAverage - taxes as a % of cigarette price - ad valorem exciseAverage - taxes as a % of cigarette price - value added taxAverage - taxes as a % of cigarette price - import dutiesTax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks)National agency for tobacco control existsNational tobacco control budget - currency reportedNumber of full-time equivalent staff in national agencyAnnual budget for tobacco control in currency reportedGovernment objectives on tobacco control existSubnational smoking bans - at least one jurisdiction has a comprehensive ban in placeMost sold brand of cigarettes - taxes as a % of price - ad valorem exciseAffordability - percentage of GDP per capita required to purchase 2000 cigarettes of the most sold brandSpecific tax component automatically adjusted for inflation (or other)Tax structure: Excise tax proportion of priceType of excise tax applied.Uniform excise tax applied Yes (Uniform), No (Tiered/varying rates)Most sold brand of cigarettes - taxes as a % of price - import dutiesMost sold brand of cigarettes - taxes as a % of price - other taxesMost sold brand of cigarettes - taxes as a % of price - specific exciseMost sold brand of cigarettes - taxes as a % of price - total taxMost sold brand of cigarettes - taxes as a % of price - value added taxTobacco tax revenues - currency reportedTobacco tax revenues - total excise (specific and ad valorem)Tobacco tax revenues - tobacco product types includedTobacco tax revenues - year reportedCheapest brand of cigarettes - currency reportedPremium brand of cigarettes - currency reportedPremium brand of cigarettes - price in currency reportedEstimate of current tobacco use prevalence (%)Estimate of current cigarette smoking prevalence (%)Most sold brand of cigarettes - price in currency reportedMost sold brand of cigarettes - currency reportedMinimum specific tax applied in ad valorem or mixed excise regimeRetail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT)Greater reliance on specific tax  in mixed excise regimeFormative research was conducted prior to the campaignOutcome evaluation was employed to assess effectiveness of the campaignCampaign was part of a comprehensive tobacco control programmeCampaign was pre-testedCampaign utilized media planningAt least one national mass media campaign ran during the survey periodEarned media/public relations were used to promote the campaignCampaign ran on both national television and radioBan on advertising on national television and radioBan on promotional discountsBan on identifying non-tobacco products with tobacco brand namesBan on use of brand name of non-tobacco product for tobacco productBan on appearance of tobacco brands in TV and/or films (product placement)Ban on appearance of tobacco products in TV and/or filmsRequired anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or imagesBan on sponsorship (contributions and/or publicity of contributions)Ban on any form of contribution (financial or other support) to any event, activity or individualBanning the publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individualsBan on tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youthBan on advertising on international television and radioBan on internet sales of tobacco productsBan on advertising in local magazines and newspapersBan on advertising in international magazines and newspapersBan on billboard and outdoor advertisingBan on product display at point of saleBan on advertising on the internetBan on free distribution in mail or through other meansSmoking cessation support is available in the communitySmoking cessation support is available in health clinics or other primary care facilitiesSmoking cessation support is available in hospitalsSmoking cessation support is available in offices of health professionalsSmoking cessation support is available in other settingsBupropion - cost coveredBupropion - legally soldBupropion - place availableSmoking cessation support is cost-covered in the communitySmoking cessation support is cost-covered in health clinics or other primary care facilitiesSmoking cessation support is cost-covered in hospitalsSmoking cessation support is cost-covered in offices of health professionalsSmoking cessation support is cost-covered in other settingsNicotine replacement therapy - on the Essential Medicines ListNicotine replacement therapy - cost coveredNicotine replacement therapy - legally soldNicotine replacement therapy - place availableAccess to a toll-free quit lineVarenicline - cost coveredVarenicline - legally soldVarenicline - place availableNumber of places smoke-free (national legislation)Smoke-free health-care facilities (national legislation)Subnational smoke-free legislation authority existsFines for violations of smoke-free lawsFines on the establishment for violations of smoke-free lawsFines on the patrons of establishments for violations of smoke-free lawsDedicated funds for enforcement of smoke-free lawsCitizen complaints and investigations of violations of smoke-free lawsSmoke-free education facilities except universities (national legislation)Smoke-free universities (national legislation)Smoke-free government facilities (national legislation)Smoke-free indoor offices (national legislation)Smoke-free restaurants (national legislation)Smoke-free pubs, bars and cafés (national legislation)Smoke-free public transport (national legislation)Smoke-free other indoor public places (national legislation)Law mandates that health warnings appear on cigarette packagesLaw mandates that health warnings appear on other smoked tobacco packagesLaw mandates that health warnings appear on smokeless tobacco packagesHealth warnings on cigarette packaging must include a photograph or graphicHealth warnings on other smoked tobacco packaging must include a photograph or graphicHealth warnings on smokeless tobacco packaging must include a photograph or graphicHealth warnings appear on each cigarette package and any outside packaging and labelling used in the retail saleHealth warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail saleHealth warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail saleHealth warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free saleHealth warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free saleHealth warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free saleHealth warnings on cigarette packaging do not remove or diminish the liability of the tobacco industryHealth warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industryHealth warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industryHealth warnings on cigarette packaging describe the harmful effects of tobacco use on healthHealth warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on healthHealth warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on healthSpecific health warnings are mandated for cigarette packagingSpecific health warnings are mandated for other smoked tobacco packagingSpecific health warnings are mandated for smokeless tobacco packagingNumber of health warnings approved by the law for cigarette packagingNumber of health warnings approved by the law for other smoked tobacco packagingNumber of health warnings approved by the law for smokeless tobacco packagingHealth warnings on cigarette packaging law requires or establishes fines for violationsHealth warnings on other smoked tobacco packaging law requires or establishes fines for violationsHealth warnings on smokeless tobacco packaging law requires or establishes fines for violationsBan on deceitful terms on cigarette packagingBan on deceitful terms on other smoked tobacco packagingBan on deceitful terms on smokeless tobacco packagingCigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptorsOther smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptorsSmokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptorsPercentage of principal display area mandated to be covered by health warnings - front and back of cigarette packagingPercentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packagingPercentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packagingCigarette packaging and labelling must not use descriptors depicting flavoursOther smoked tobacco packaging and labelling must not use descriptors depicting flavoursSmokeless tobacco packaging and labelling must not use descriptors depicting flavoursCigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademarkOther smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademarkSmokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademarkCigarette packaging and labelling must display qualitative information on emission yieldsOther smoked tobacco packaging and labelling must display qualitative information on emission yieldsSmokeless tobacco packaging and labelling must display qualitative information on emission yieldsEmission yields must be displayed on one or more principle display areas of cigarette packagingEmission yields must be displayed on one or more principle display areas of other smoked tobacco packagingEmission yields must be displayed on one or more principle display areas of smokeless tobacco packagingDisplay of expiry dates is prevented on cigarette packagingDisplay of expiry dates is prevented on other smoked tobacco packagingDisplay of expiry dates is prevented on smokeless tobacco packagingThe quit line number must appear on cigarette packaging or labellingThe quit line number must appear on other smoked tobacco packaging or labellingThe quit line number must appear on smokeless tobacco packaging or labellingPlain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)Percentage of principal display area mandated to be covered by health warnings - front of cigarette packagingPercentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packagingPercentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packagingPercentage of principal display area mandated to be covered by health warnings - back of cigarette packagingPercentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packagingPercentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packagingHealth warnings on cigarette packaging must be placed at the top of the principal display areas of the packageHealth warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the packageHealth warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the packageFont style, font size and colour of health warnings are mandated for cigarette packagingFont style, font size and colour of health warnings are mandated for other smoked tobacco packagingFont style, font size and colour of health warnings are mandated for smokeless tobacco packagingHealth warnings on cigarette packaging must be rotatedHealth warnings on other smoked tobacco packaging must be rotatedHealth warnings on smokeless tobacco packaging must be rotatedHealth warnings on cigarette packaging must be written in the principal language(s) of the countryHealth warnings on other smoked tobacco packaging must be written in the principal language(s) of the countryHealth warnings on smokeless tobacco packaging must be written in the principal language(s) of the countryHealth warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stampsHealth warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stampsHealth warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stampsEnforce bans on tobacco advertisingMonitorOffer help to quit tobacco useProtect from tobacco smokeRaise taxes on tobaccoWarn about the dangers of tobaccoAnti-tobacco mass media campaignsCytisine - legally soldCytisine - place availableCytisine - cost coveredCompliance with ban on advertising on national television and radio (score)Compliance with ban on promotional discounts (score)Compliance with ban on use of brand name of non-tobacco product for tobacco product (score)Compliance with ban on indentifying non-tobacco products with tobacco brand names (score)Compliance with ban on appearance of tobacco brands in TV and/or films (score)Compliance with ban on appearance of tobacco products in TV and/or films (score)Compliance with ban on sponsorship (contributions and/or publicity of contributions) (score)Compliance with ban on advertising in local magazines and newspapers (score)Compliance with ban on billboard and outdoor advertising (score)Compliance with ban on advertising at point of sale (score)Compliance with ban on free distribution in mail or through other means (score)Overall compliance with regulations on smoke-free environments (score)Compliance with smoke-free health-care facilities law (score)Compliance with smoke-free education facilities except universities law (score)Compliance with smoke-free universities law (score)Compliance with smoke-free government facilities law (score)Compliance with smoke-free indoor offices law (score)Compliance with smoke-free restaurants law (score)Compliance with smoke-free pubs and bars law (score)Compliance with smoke-free public transport law (score)Year of most recent survey of adultsRepresentativeness of most recent survey of adultsAge range of most recent survey of adultsTitle of most recent survey of adultsName of latest adult prevalence survey (nonsmoked)Year of latest adult prevalence survey (nonsmoked)Representation of latest adult prevalence survey (nonsmoked)Age range of latest adult prevalence survey (nonsmoked)Prevalence of current tobacco use among adults (%)Prevalence of daily tobacco use among adults (%)Prevalence of current tobacco smoking among adults (%)Prevalence of daily tobacco smoking among adults (%)Prevalence of current cigarette smoking among adults (%)Prevalence of daily cigarette smoking among adults (%)Prevalence of current smokeless tobacco use among adults (%)Prevalence of daily smokeless tobacco use among adults (%)Prevalence of current e-cigarette use among adults (%)Prevalence of daily e-cigarette use among adults (%)Ban on sale of duty-free or excise-free cigarettesAffordability – category of change 2010-2020 (Yes (less affordable), No (more affordable), No change).Reported use of earmarked tobacco taxesTax stamps, fiscal marks, banderole or other types of marking are applied on cigarettesTax stamps, fiscal marks, banderole or other types of marking are applied on other tobacco productsA minimum price policy is implementedCheapest brand of cigarettes - price in currency reportedCheapest brand of cigarettes - price in PPP$Cheapest brand of cigarettes - price in US$ at official exchange ratesMost sold brand of cigarettes - price in PPP$Most sold brand of cigarettes - price in US$ at official exchange ratesPremium brand of cigarettes - price in PPP$Premium brand of cigarettes - price in US$ at official exchange ratesPrevalence of current smokeless tobacco use among adolescents (%)Prevalence of current e-cigarette use among adolescents (%)Prevalence of current cigarette smoking among adolescents (%)Estimate of current tobacco use prevalence (%) (age-standardized rate)Estimate of current tobacco smoking prevalence (%)Estimate of current tobacco smoking prevalence (%) (age-standardized rate)Estimate of current cigarette smoking prevalence (%) (age-standardized rate)Title of most recent adolescent surveyYear of most recent adolescent surveyRepresentativeness of most recent adolescent surveyName of latest youth prevalence survey (nonsmoked)Year of latest youth prevalence survey (nonsmoked)Representation of latest youth prevalence survey (nonsmoked)Age range of latest youth prevalence survey (nonsmoked)Age range of most recent adolescent surveyProcess evaluation was employed to assess implementation of the campaignOverall compliance with bans on promotion and sponsorship (score)Ban on Corporate Social Responsibility activities (CSR)Ban on tobacco companies/the tobacco industry publicizing their CSR activitiesBan on entities other than tobacco companies/the tobacco industry publicizing the CSR activities of the tobacco companies/industryLaw requires fines for violations of advertising bansLaw requires fines for violations of promotion and sponsorship bansSubnational bans on tobacco advertising, promotion and sponsorship authority existsBan on tobacco vending machinesBan on advertising at point of saleOverall compliance with bans on direct advertising (score)Status of bejel endemicityStatus of pinta endemicityNumber of cases of cutaneous leishmaniasis reportedStatus of yaws endemicityStatus of endemicity of cutaneous leishmaniasisStatus of endemicity of visceral leishmaniasisNumber of imported cases of cutaneous leishmaniasis reportedLegislationCoordinationSurveillanceResponsePreparednessRisk communicationHuman resourcesLaboratoryPoints of entryZoonosisFood safetyChemicalRadionuclearAlcohol-related road traffic crashes with fatalities, per 100,000  populationElectric field (kV/m)Electric field (kV/m) low frequencyAlcohol-related crimes (% of all crimes)National drinking guidelines,2016Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CIFood Safety (SPAR)Surveillance (SPAR)Risk Communication (SPAR)Human Resources (SPAR)Laboratory (SPAR)Points of Entry (SPAR)Compliance with international health regulationsUHC Service Coverage Index (SDG 3.8.1)UHC Service Coverage sub-index on service capacity and accessUHC Service Coverage sub-index on reproductive, maternal, newborn and child healthUHC Service Coverage sub-index on infectious diseasesUHC Service Coverage sub-index on noncommunicable diseasesPrimary data availability for UHC Service Coverage Index (SDG 3.8.1) (%)Donor/ non-public development funding for eHealthProportion of donor/non public development fundingGovernment-supported health internet sites provide information in multiple languagesInstitutions offer in-service training to health professionals on ICT for healthProportion ofpublic private partnerships fundingstrategy refers to the use of ICT to support UHCProportion of public fundingPublic funding for eHealthStrategy implementation funding available for eHealthPrivate funding for eHealthTertiary institutions provide students of health sciences with training on eHealthNational  health information system (HIS) policy or strategyPublic-private partnerships for eHealthProportion of private fundingNational universal health coverage strategyNational eHealth strategy refers to objectives of UHCNational eHealth strategyDemandCost-effectivenessRegulating mobile devices and softwarePromoting the development and adoption of mHealthGovernment-sponsored mHealth programmes are being evaluatedPromoting standards and interoperabilitymHealth programmes are sponsored by governmentFundingCapacityLegalInfrastructureProviding guidance on privacy and securityProviding incentives and guidance for innovation research and evaluation of healthEffectivenessRegulatory oversight of mobile apps for quality, safety and reliabilityProviding oversight and enforcement of data ownershipPolicyPrioritiesCountry has telehealth policy or strategyEvaluation of any government-sponsored telehealth programmesStrategy includes objectives as to how telehealth contributes to UHCeLearning is used in pre-service education to teach health sciences studentsLack of evidence over cost-effectivenesseLearning programmes for in-service training of health professionals have been evaluatedImproving access to content and experts (in-service)eLearning used for in-service training of health professionalsInsitutional educational policy does not include eLearning as an approach to teaching health sciencesLack of demand for eLearning programmesImproving access to content and experts (pre-service)Competing educational prioritiesLack of capacityPre-service eLearning programmes have been evaluatedReducing cost of delivering content (pre-service)eLearning courses accredited by continuing medical education or professional licensing bodiesLack of suitable courses availableReducing cost of delivering content (in-service)Enabling access to education where learning facilities are limited (pre-service)Lack of fundingLack of evidence that eLearning is effectiveEnabling access to education where learning facilities are limited (in-service)Not possible to gain a health sciences degree entirely through eLearningLack of infrastructureNational strategy does not promote the adoption of EHRLack of evidence showing cost-effectiveness or EHRLack of capacity (for EHR)Country has specific legislation governing the use of national EHR systemLack of infrastructure (for EHR)Lack of funding (for EHR)Competing health system prioritiesLack of national or international standards for interoperability of EHRCountry has national EHRlack of evidence showing effectiveness of EHRLack of demand by health professionals and patientsLack of legislation or regulations covering use of EHRto protect the privacy of individuals' health-related  data held in electronic format as an EHRwhich allows for the sharing of personal and health data between research entitieswhich allows individuals to demand that their own data be corrected  when held in an EHR if it is known to be inaccuratePolicy or strategy makes specific reference tothe use of social media in the health domainto define medical jurisdiction, liability or reimbursement of eHealth services such as telehealthwhich governs the sharing of digital data between health professionals  in health services in other countries through the use of an EHRIndividuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choiceto address patient safety and quality of care based on data quality, data transmission standards, or clinical competency criteriawhich allows individuals to demand the deletion of health-related data from their EHRwhich governs the sharing of digital data between health professionals in other health services in the same country through the use of an EHRCountry has national policy or strategy on the use of social media by government organizationswhich allows individuals electronic access to their own health-related data when held in an EHRto protect privacy of personally identifiable data of individuals irrespective of whether it is paper or digital formatEffective standards and best practices for data capture not fully establishedResearch into new analytical methods needs occur to meet the challenges of working with big dataCountry has national policy or strategy regulating the use of big data by private companiesCapacity building required for new skillsLack of integration between various health servicesInsufficient incentives for data sharingCountry has  national policy or strategy regulating the use of big data in the health sectorPrivacy and security laws need to be in placeGovernment unit/official responsible for prevention for substance useMinistry/office that takes primary responsibility for prevention for substance useFive years change in international cooperation for prevention for substance useGovernment unit/official responsible for treatment of substance use disordersMinistry/office that takes primary responsibility for treatment of substance use disordersInvolvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disordersInvolvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disordersInvolvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugsInvolvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugsFive years change in international cooperation for treatment of substance use disordersConfidentiality of people in treatment for substance use disordersVoluntary treatment for people with alcohol use disorders in the criminal justice systemCompulsory treatment for people with alcohol use disorders in the criminal justice systemCompulsory treatment for people with drug use disorders in the criminal justice systemVoluntary treatment for people with drug use disorders in the criminal justice systemFive-year change in government resources for prevention for substance useFive-year change in government resources for treatment of substance use disordersFinancing methods for treatment for alcohol use disordersFinancing methods for treatment for drug use disordersGovernment benefits for people with alcohol use disordersGovernment benefits for people with drug use disordersHypothecated taxes to be spent on prevention and treatment for substance use disordersMain sector for treatment for drug use disordersTreatment programmes for children and adolescents with alcohol use disorders (treatment)Treatment programmes for children and adolescents with drug use disorders (treatment)Specialized treatment facilities for substance use disordersSpecialized treatment facilities for alcohol use disordersSpecialized treatment facilities for drug use disordersSelf-help groupsMain sector for treatment for alcohol use disordersMain substance at treatment entryReported treatment coverage for substance dependenceGuidelines on pharmacological treatment for substance use disordersPharmacotherapy with methadonePharmacotherapy with buprenorphinePharmacotherapy with buprenorphine/naloxoneAccess restrictions to maintenance treatmentTimeframe for maintenance treatment of opioid dependenceRegistration of medications for alcohol dependence and withdrawalRegistration of medications for opioid dependenceRegistration of medications for opioid withdrawalRegistration of naloxone for injection for opioid overdoseAvailability of naloxoneScreening and brief intervention for substance use in primary health careScreening and brief intervention for substance use in antenatal servicesRecommendations for screening and brief interventions for substance use in primary health careRecommendations for screening and brief interventions for substance use in antenatal servicesGroups and agencies involved in prevention programsPrevention programmes for alcoholPrevention programmes for specific populations for alcoholPrevention programmes for drugsPrevention programmes for specific populations for drugsHIV, Hepatitis counselling and treatment availability in specialized facilities and servicesProgrammes readily availableStandards of treatment and care for public specialized treatment facilitiesSpecial treatment programmes for gambling disorderTreatment programmes for women with alcohol use disordersTreatment programmes for women with drug use disordersSpecial housing services for alcohol use disordersSpecial housing services for drug use disordersEmployment services for alcohol use disordersEmployment services for drug use disordersOpen access interventions for alcoholOpen access interventions for drugsHealth professionals providing treatment for alcohol and drug use disordersStandards of care for professionals providing treatment for alcohol and drug use disordersEducational attainment in preventionPostgraduate training programme in preventionContinuing professional development in preventionEducational attainment in treatmentPostgraduate training programme in treatmentContinuing professional development in treatmentEpidemiological data collection for substance useService delivery data collection for substance useRegular reports on epidemiological and service delivery data for substance useEpidemiological data collection system for substance use among children and adolescents (see RSUD_880)System of monitoring alcohol involvement in forensic pathologySystem of monitoring drugs involvement in forensic pathologyEpidemiological data collection system for substance use among children and adolescentsTreatment programmes for children and adolescents with alcohol use disorders (youth)Treatment programmes for children and adolescents with drug use disorders (youth)Availability of estimates on impoverishment due to out-of-pocket health expendituresAvailability of estimates on large health expenditures as a share of total expenditure or incomePopulation with household spending on health greater than 10% of total household budget (SDG 3.8.2, reported data) (%)Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, reported data) (%)Population pushed below the $1.90 a day poverty line by household health expenditures (%)Population pushed below the $3.20 a day poverty line by household health expenditures (%)Population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)Population pushed further below the $1.90 a day poverty line by household health expenditures (%)Population pushed further below the $3.20 a day poverty line by household health expenditures (%)Population pushed further  below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)Increase in poverty gap due to household health expenditures, expressed as a proportion of the $1.90 a day poverty line (%)Increase in poverty gap due to household health expenditures, expressed as a proportion of the $3.20 a day poverty line (%)Increase in poverty gap due to household health expenditures, expressed as a proportion of a relative poverty line (60% of median daily per capita consumption or income) (%)Number of deaths attributed to non-communicable diseases, by type of disease and sexNursing personnel (number)Midwifery personnel (number)Dental Assistants and Therapists (number)Pharmaceutical Technicians and Assistants (number)Medical and Pathology Laboratory scientists (number)Medical and Pathology Laboratory Technicians (number)Physiotherapists (number)Physiotherapy Technicians and Assistants (number)Medical doctors (%)Nursing personnel (%)Medical doctors not further defined (number)Medical doctors (number)Medical doctors (per 10 000 population)Nursing and midwifery personnel  (number)Dentists (number)Dentists (per 10 000 population)Pharmacists (number)Pharmacists  (per 10 000 population)Nursing and midwifery personnel (per 10 000 population)Reporting countriesProportion of isolates with resistance to azithromycin reported to WHO-GASPProportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASPProportion of isolates with resistance to ciprofloxacin reported to WHO-GASPProportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASPProportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASPNumber of isolates tested for azithromycinNumber of isolates tested for cefiximeNumber of isolates tested for ciprofloxacinNumber of isolates tested for ceftriaxoneNumber of isolates tested for extended-spectrum cephalosporinsICD-11 implementation progress levelInstitutional Births (birth taken place in a facility) (%)Number of reported cases of poliomyelitis by wild poliovirus (WPV)Births in baby-friendly facilities (%)Nutrition Governance scoreInternational Code on Marketing of Breast-milk Substitutes: Legal status of the CodeMaternity protection: Compliance with international labour standardsGDP per capita annual growth rate (%)